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Abstract
Background Bioabsorbable fixation systems have been
widely employed in pediatric patients for cranial recon-
struction, obviating the complications of hardware mi-
gration and imaging artifact occurring with metallic
implants. Recent concern over complications unique to
bioabsorbable materials, such as inflammatory reaction
and incomplete resorption, necessitates additional con-
clusive studies to further validate their use in pediatric
neurosurgery and craniofacial surgery. Likewise, long-
term follow-up in this clinical cohort has not previously
been described.
Methods We included consecutive pediatric patients un-
der the age of 2, from Lucile Packard Children’s Hos-
pital, who underwent cranial vault reconstruction with
the use of a bioabsorbable fixation system between
2003 and 2010. Hospital records were queried for pa-
tient characteristics, intraoperative data, and postopera-
tive complications.
Results Ninety-five patients with the following preoper-
ative pathologies were analyzed: craniosynostosis (87),
cloverleaf skull (5), frontonasal dysplasia (1), and fron-
tonasal encephalocele (2). Median age was 6 months
(range 1–24 months). Average case duration was
204 minutes (range 40–392 min), with median of
154 mL blood loss (range 30–500 mL). Ninety-three
percent of patients had 1–4 plates implanted with
48 % receiving three plates. The median number of
screws used was 59 (range 0–130). The median length
of hospital stay was 4 days (range 2–127 days) with an
average follow-up of 22 months (five postoperative vis-
its). The complications related to hardware implantation
included swelling (1 %) and broken hardware (1 %), the
latter of which required reoperation.
Discussion The bioabsorbable fixation systems for cranial
vault reconstruction in children less than 2 years of age is
safe with tolerable morbidity rates.
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Introduction
Bioabsorbable fixation systems have been widely employed
for use in pediatric patients for cranial reconstruction since
1997, obviating the complications of hardware migration
and imaging artifact occurring with metallic implants. Re-
cent concern over complications unique to bioabsorbable
materials, such as inflammatory reaction and incomplete
resorption [3, 8, 10, 14, 15], necessitates additional conclu-
sive studies to further validate their use in pediatric cranio-
facial surgery. Here, we present a retrospective analysis of
children younger than 2 years of age who underwent cra-
niofacial procedures with a bioabsorbable plating system.
Methods
This was a HIPPA-compliant, IRB-approved research proto-
col, accessing password and firewall-protected patient data-
bases. Hospital records from Lucile Packard Children’s
Hospital (LPCH) were retrospectively queried on consecutive
pediatric patients who underwent cranial vault reconstruction
with a bioabsorbable plating system (RapidSorb® Synthes
CMF, West Chester, PA, L-lactide-co-glycolide) between
2003 and 2010. At our institution, this is the predominant
system employed; therefore, to remove any potential variabil-
ity between industrial product formulation, only patients with
this specific bioabsorbable fixation system were included.
Inclusion criteria included age less than 2 years, diagnosis of
a skull or facial deformity requiring combined neurosurgery
and plastic surgical intervention, and intraoperative use of
bioabsorbable plates. Hospital records were queried for pa-
tient demographics, preoperative diagnoses, intraoperative
data, and postoperative complications.
Funding was provided in part by an industry sponsored
indirect educational grant to Stanford University to fund
aspects of this study. The Synthes company administration
and representatives had no contact with the study staff
regarding the study design or results. Furthermore, the out-
come of this study was not discussed with industry prior to
data analysis or manuscript production. Ethical considera-
tions of this educational grant were weighed heavily and
ultimately approved by the Dean of the Stanford University
School of Medicine.
Results
Ninety-five patients with the following preoperative patholo-
gies were analyzed: craniosynostosis (n087), cloverleaf skull
(n05), frontonasal dysplasia (n01), and frontonasal encepha-
locele (n02). Median age was 6 months (range 1–24 months),
with 83 % of patients less than 12 months of age. Forty-six
percent of patients were female (n044) and 54 % were male
(n051). Demographic information as documented by self-
report from patients’ families was collected and included an
ethnic distribution of: White, non-Hispanic (55 %), Hispanic
(29 %), Black (2 %), Asian (13 %), and Native American
(1 %). Sixty percent of patients had private insurance, 39 %
had Medi-Cal, and one patient was without insurance.
Table 1 details the diagnoses included in the study, in-
cluding the suture involved and the relative frequency of
any associated syndrome. Three cases were identified as
reoperations. Comorbidities were found in 22 % of patients
(n021) with each detailed by system in Table 2. Eleven
patients had preoperative developmental delay.
Average case duration was 204 min (range 40–392 min),
with median of 154 mL blood loss (range 30–500 mL).
Postoperatively, the threshold to receive a transfusion was
a hematocrit of 22. Ninety-three percent of patients received
a blood transfusion either intra- or postoperatively, with a
median transfused volume of 150 mL (range 0–1,000 mL).
Ninety-three percent of patients had one to four plates
implanted with 48 % receiving three plates (Table 3). The
median number of screws used was 59 (range 0–130).
Table 1 Diagnosis, syndromes, and involved sutures
Patients
Cases (%)
Diagnosis
Craniosynostosis 87 (92)
Frontonasal dysplasia 1 (1.1)
Frontonasal encephalocele 2 (2.1)
Kleeblattschädel 5 (5.3)
Total 95 (100)
Suture involvementa
Unilateral coronal 28 (29)
Bilateral coronal 12 (13)
Lamboid 7 (7.4)
Sagittal 10 (11)
Multiple 6 (6.3)
Total 87 (91)
Syndromeb
Apert 3 (3.2)
Crouzon 2 (2.1)
Downs 1 (1.1)
Muenke 1 (1.1)
Pfeiffer 1 (1.1)
Saethre–Chotzen 3 (3.2)
Sotos 1 (1.1)
Total 12 (13)
a Craniosynostosis cases only
bWhere a known syndrome was diagnosed in addition to craniosynostosis
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The median length of hospital stay was 4 days (range 2–
127 days). The average follow-up was 22 months (range 0.5–
74; median 17) and the patients had an average of five post-
operative visits (range 1–10, median 5). Overall, 91 % of all
cases had no complications. Postoperative complications relat-
ed to surgery included pneumonia (1 %) and superficial wound
infection (3 %). Complications related to the hardware includ-
ed one broken strut plate (1 %) and one patient with swelling at
the site of the plate 7 months after surgery with complete
resolution at 11 months (1 %). The wound infections were
superficial and required only outpatient antibiotic treatment for
resolution. Three patients were preoperatively determined to
require a staged reconstruction for their cranial deformity. Two
cases of unanticipated reoperations included one for persistent
facial and cranial deformity several months after surgery and
one for broken hardware on postoperative day 1.
Discussion
Surgical correction of cranial and facial deformities in children
requires the unique consideration of the child’s growing skull
while maintaining acceptable stability to enable osteogenesis.
Resorbable plates and screws attempt to avoid the problems
with metal fixation systems, including erosion into the dura
and brain parenchyma, imaging artifact, and restriction of
bone growth. Multiple studies have documented the use of
these products in the repair of craniosynostosis and other
pediatric cranial deformities (Table 4).
Resorbable fixation systems in cranial surgery have been
found to provide stable cranial fixation, which allow for
normal expansion of the cranial vault, while avoiding prob-
lems with migration or increased complication rates com-
pared to metal alternatives [1, 7–9, 12, 14, 15, 17].
Complications with bioavailable fixation systems include
inadequate resorption, osteolysis, inflammatory foreign
body reaction, plate extrusion, and infection [3, 8, 10, 14,
15]. Recently, the use of these materials has expanded to
include combination with hydroxyapatite cement for more
extensive reconstruction procedures [4, 11, 16], reconstruc-
tion after trauma [6], and reconstruction of the orbit [2].
Animal studies have shown negligible involvement of the
dura and brain parenchyma directly underlying the bioab-
sorbable materials [5]. Histologic examination of resorbable
plates has showed fibrous encapsulation of the plates, with a
foreign body macrophage and giant cell reaction and calci-
fication [5, 13, 14].
Recent concerns, particularly in regard to the inflamma-
tory reaction, necessitated further evaluation of the risks and
benefits of resorbable fixation systems in young children
[3]. To decrease variability in age, surgeon, and implants,
we elected to study children under the age of 2, where the
same resorbable system was utilized, operated on by our
combined pediatric neurosurgery and plastic surgery team at
LPCH. As with previous studies, over 90 % of patients had
an excellent outcome with only one case of inflammation or
broken hardware. Inflammation typically occurs within the
first 12 months after implantation [3] which was accounted
for with our mean follow-up time of 22 months. Another
factor that can influence the outcome is comorbidities. De-
spite having 22 % of the patients in this cohort with other
comorbidities (Table 2), the overall surgical and bioabsorb-
able material-related complications were not higher than in
other published series. The unanticipated return to the oper-
ating room due to a broken plate was evident on postoper-
ative day 1. The underlying cause of this plate fracture is
unclear.
Our cohort has the advantages of a predefined age group,
consistency in surgeons and implant product, a variety of
sutures and syndromes involved, and extended follow-up.
Our standard postoperative follow-up schedule includes vis-
its at 1, 3, 6, and 12 months and the average in this series
was five postoperative visits. Over 80 % of patients in this
series have at least 12 months of follow-up, substantially
decreasing the risk of a missed event. A limitation of this
study is the retrospective, case series design; however, given
Table 2 Medical comorbidities by system in 21 patients
System and disease Cases (%)
Cardiovascular 4 (4.2)
Endocrine 1 (1.1)
Gastrointestinal 3 (3.2)
Genetic 2 (2.1)
Neurologic 10 (11)
Prematurity 2 (2.1)
Pulmonary 5 (5.3)
Renal 1 (1.1)
Torticollis 3 (3.2)
Total 32
Table 3 Distribution of the number of plates installed per patient
Number of plates Patients
Cases (%)
1 8 (8.4)
2 20 (21.1)
3 46 (48.4)
4 14 (14.7)
5 6 (6.3)
–a – –
9 1 (1.1)
a No patients required six, seven, or eight plates
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the low number of patients and good outcome with resorbable
plates, a randomized, prospective clinical trial is impractical.
Overall, in comparison to prior studies of resorbable plates,
our cohort confirms bioavailable fixation systems to be safe
and effective for the treatment of craniofacial deformities in
children.
Conclusion
The bioabsorbable fixation system for cranial vault recon-
struction in children less than 2 years of age is safe with very
low morbidity rates. In our cohort, the risk of inflammation
related to bioabsorbable fixation system was 1 %. It is
Table 4 Literature review of resorbable fixation use in pediatric skull deformities
Primary
author
Year Implant No. of
patients in
study
Age
(mean,
range;
months)
Diagnoses
included
Mean
length of
follow-up
(months)
Complications
(n, %)
Eppley 1997 LactoSorba 100 9, 6–12 Craniosynostosis 15, 6–24 0, 0
Goldstein 1997 LactoSorb 8 38, 6–120 Craniosynostosis
and encephalocele
4.5 1, 12.5
Kumar 1997 LactoSorb 22 76, 5–228 Craniosynostosis
and congenital
craniofacial lesions
0.5–4 1, 4.5
Tharanon 1998 LactoSorb 33 –, 4–144 Craniosynostosis,
Hydrocephalus
and congenital
craniofacial lesions
12 1, 3.0
Aria 2000 Fixsorbb 3 –, 2–10 Craniosynostosis 16–18 0, 0
Kurpad 2000 LactoSorb 51 36, 1–120 Craniosynostosis and
encephalocele
24 2, 3.9
Imola 2001 LactoSorb 55 17, 5–78 Craniosynostosis,
craniofacial syndromes,
and acquired disorders
6–36 4, 7.0
Burstein 2002 LactoSorb 21 53, 0.2–180 Craniofacial
syndromes
24 2, 9.5
Cohen 2002 MacroPorec 5 –, 3–8 Sagittal synostosis 3–12 0, 0
Eppley 2004 LactoSorb 1883 –, <24 Frontal synostosis
and occipital
deformation
– 25, 1.3
Burstein 2006 LactoSorb 60 7, 4–15 Craniosynostosis 24 8, 13
Greenburg 2006 RapidSorbd, Bone Cementa, d 50 6, 0.25–24 Metopic synostosis 144 1, 2
Serlo 2007 PLGAe 10 14, 7–35 Craniosynostosis 42 1, 10
Sanger 2007 Craniosorbf, Bioasorb PDXg, LactoSorb 52 8, 2–49 Craniosynostosis 17 3, 5.8
Ahmad 2008 LactoSorb 146 15, 2–192 Craniosynostosis 12 5, 3.4
Aldana 2008 Sonic Weldingh 28 66, 2–216 Craniosynostosis,
tumor, and traumatic
injury
11.5 1, 3.6
Arnaud 2009 Sonic Weldingh 20 16, 3–30 Craniosynostosis
and congenital
craniofacial defect
>30 1, 5
Munoz-Casado 2009 LactoSorb 216 6, 4–24 Craniosynostosis 6–60 7, 3.2
Guzman 2011 RabidSorb 70 6.5, 1–27 Craniosynostosis 15 2, 2.9
– unavailable
a Lorenz Surgical, BioMet, Jacksonville, FL
b Fixsorb-MX; Takiron Co., Ltd., Osaka, Japan
cMacroPore, Inc., San Diego, CA
d Synthes Inc, Paoli, PA
e Biosorb PDX or Inion CPS baby, Tampere, Finland
f Codman-Johnson & Johnson, Raynham, MA
gBionx Implants Inc, Blue Bell, PA
h SonicWeld Rx, KLS Martin L.P.
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important to disclose to families the risks and benefits of
using these systems, as summarized in our review.
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